Skip to content
Gold Mining News – Lifestyle
Author:
OnKure Therapeutics, Inc.
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
August 4, 2026
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
July 2, 2026
OnKure Therapeutics Reports First Quarter 2026 Financial Results
May 5, 2026